AtriCure, Inc. Files 8-K on Operations and Financials
Ticker: ATRC · Form: 8-K · Filed: May 1, 2024 · CIK: 1323885
Sentiment: neutral
Topics: sec-filing, operations, financials
Related Tickers: ATRC
TL;DR
ATRC filed an 8-K. Standard ops & financials update.
AI Summary
On May 1, 2024, AtriCure, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This filing indicates AtriCure is providing updated operational and financial information to the SEC, which is crucial for investors to assess the company's performance and health.
Risk Assessment
Risk Level: low — This is a routine filing of operational and financial information, not indicating any immediate material changes or risks.
Key Players & Entities
- AtriCure, Inc. (company) — Registrant
- May 1, 2024 (date) — Date of Report
- 7555 Innovation Way, Mason OH 45040 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing by AtriCure, Inc.?
The primary purpose of this 8-K filing is to report on AtriCure, Inc.'s Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on May 1, 2024.
What is AtriCure, Inc.'s principal executive office address?
AtriCure, Inc.'s principal executive office is located at 7555 Innovation Way, Mason, OH 45040.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed as a Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is AtriCure, Inc.'s state of incorporation and IRS Employer Identification No.?
AtriCure, Inc. is incorporated in Delaware and its IRS Employer Identification No. is 34-1940305.
Filing Stats: 579 words · 2 min read · ~2 pages · Grade level 9.4 · Accepted 2024-05-01 16:00:37
Filing Documents
- atrc-20240501.htm (8-K) — 28KB
- exhibit991-05012024.htm (EX-99.1) — 115KB
- image_0a.jpg (GRAPHIC) — 3KB
- 0001323885-24-000060.txt ( ) — 278KB
- atrc-20240501.xsd (EX-101.SCH) — 2KB
- atrc-20240501_lab.xml (EX-101.LAB) — 21KB
- atrc-20240501_pre.xml (EX-101.PRE) — 12KB
- atrc-20240501_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On May 1, 2024 , AtriCure, Inc. issued a press release regarding its financial results for the first quarter ended March 31, 2024. The Company will hold a conference call on May 1, 2024 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in Item 2.02 of Form 8-K and in the press release attached as Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in each of Item 2.02 of this Form 8-K and Exhibit 99.1 shall not be incorporated by reference in any filing or other document under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing or document.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits No. Description 99.1 Press Release dated May 1, 2024 relating to financial results for the first quarter ended March 31, 2024. 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATRICURE, INC. Dated: May 1, 2024 By: /s/ Angela L. Wirick Angela L. Wirick Chief Financial Officer